Figure 2From: MVP expression in the prediction of clinical outcome of locally advanced oral squamous cell carcinoma patients treated with radiotherapyMVP/IGF-1R expression and clinical outcome in oral carcinoma patients suffering from tumour stages III-IV (n = 66). (a) Local Disease Free Survival, (b) Disease-Free Survival, and (c) Cause-Specific Surviva.Back to article page